BRIEF published on 04/30/2024 at 13:05, 1 year 9 months ago Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema Clinical Trial Cell Therapy Emmecell Corneal Edema Non-surgical Treatment
PRESS RELEASE published on 04/30/2024 at 13:00, 1 year 9 months ago Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema Emmecell completes final dose administration for the last patient in U.S. trial for EO2002, a non-surgical cell therapy for corneal edema, showing promise for treating vision loss Clinical Trial Cell Therapy Emmecell Corneal Edema EO2002
Published on 02/02/2026 at 00:05, 8 hours 45 minutes ago Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 2 days 5 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 2 days 7 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 02/02/2026 at 08:30, 19 minutes ago M1 Kliniken AG: Completion of the Sale of 100% Subsidiary HAEMATO Pharm GmbH to PHOENIX group
Published on 02/02/2026 at 08:05, 44 minutes ago Hyundai Mobis Secured Over 9 Billion USD in Orders from Global Automakers Last Year
Published on 01/30/2026 at 17:45, 2 days 15 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 3 days 14 hours ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 3 days 15 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
